{"id":"W3036451283","doi":"10.1016/s2352-3026(20)30205-2","title":"Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts","year":2020,"lang":"en","type":"review","venue":"The Lancet Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; National Institutes of Health; Sierra Oncology; National Institute for Health and Care Research; Omeros Corporation; Argenx; Pfizer; Incyte; CTI Biopharma; Astellas Pharma; Eisai; Celltrion; Agios Pharmaceuticals; MEI Pharma; Syndax Pharmaceuticals; Acceleron; Astex Pharmaceuticals; Celgene; PTC Therapeutics; Arog Pharmaceuticals; National Center for Advancing Translational Sciences; Medical Research Council; Teva Pharmaceutical Industries; Helsinn; Jazz Pharmaceuticals; Array BioPharma; University of Toronto; Apellis Pharmaceuticals; Alexion Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; TG Therapeutics; MacroGenics; Celldex Therapeutics; Cardinal Health; Amgen","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Intensive care medicine; 2019-20 coronavirus outbreak; Myeloid leukemia; Oncology; Internal medicine; Virology; Disease; Outbreak","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01192383,0.001243345,0.004206764,0.002362399,0.0006476207,0.003285089,0.002789969,0.006062326,0.004235262],"category_scores_gemma":[0.02068208,0.0006505954,0.003942277,0.00200547,0.001143213,0.003785238,0.002560712,0.01009697,0.0016461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003417053,"about_ca_system_score_gemma":0.01404624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008954696,"about_ca_topic_score_gemma":0.02357438,"domain_scores_codex":[0.9953517,0.00176251,0.001301013,0.0002891657,0.001007346,0.0002882348],"domain_scores_gemma":[0.9869673,0.006692077,0.001910299,0.0001682048,0.003518952,0.0007431827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003583423,0.0001081145,0.000592596,0.05188842,0.0007058908,0.0002553204,0.0002640962,0.0005496178,0.000453611,0.005179175,0.2617164,0.6779284],"study_design_scores_gemma":[0.0003606221,0.0001413293,0.001587052,0.1167241,0.001153418,0.0004337683,0.000339304,0.0001993171,0.0001679877,0.00422432,0.8745979,0.00007095648],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008938776,0.962265,0.0002866941,0.03267117,0.003556286,0.00006100542,0.00009860026,0.00001817426,0.0009536689],"genre_scores_gemma":[0.001286026,0.9648819,0.002564215,0.02722486,0.00306598,0.0001379572,0.0001770181,0.000010265,0.0006518013],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01192383,"threshold_uncertainty_score":0.06306005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1501999594180515,"score_gpt":0.4148418345378975,"score_spread":0.264641875119846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}